Express Scripts, Inc. (ESRX) Posts Mixed Q4 Results

Express Scripts, Inc. (NASDAQ: ESRX) reported Q4 EPS of $0.82, $0.03 worse than the analyst estimate of $0.85. Revenue for the quarter came in at $12.1 billion versus the consensus estimate of $11.6 billion.

For earnings history and earnings-related data on Express Scripts, Inc. (ESRX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• BK Technologies (BKTI) Tops Q2 EPS by 11c
• Cellectar Biosciences (CLRB) Misses Q2 EPS by 9c